Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
UTILITY Therapeutics Joins Antimicrobials Working Group PR Newswire WASHINGTON, Feb. 17, 2021 WASHINGTON, Feb. 17, 2021 /PRNewswire/ -- The...
Shares in antibiotics developer Summit Therapeutics PLC were cancelled in London on Monday, a condition of its USD50 ...
AIM 24 February 2020 NOTICE 24/02/2020 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON At the request of the Company the following...
FTSE Russell 17 February 2020 Summit Therapeutics (UK): Constituent Deletion Changes in FTSE UK Index Series 17 February 2020 Subject to the...
M Summit Therapeutics plc ("Summit Therapeutics" or the "Company") AIM Delisting Reminder Oxford, UK, and Cambridge, MA, US...
M Summit Therapeutics plc ("Summit Therapeutics" or the "Company") Notification of Transaction of Persons Discharging...
Summit Therapeutics PLC on Thursday said it has achieved the first USD1 million milestone payment under its license a ...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics to Receive $1.0 Million Milestone Payment from...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics to Present at the 2020 BIO CEO & Investor...
M Summit Therapeutics plc ('Summit' or the 'Company') Exercise of Restricted Stock Units Oxford, UK, and Cambridge, MA, US, 27...
Summit Therapeutics PLC on Friday said its chief operating officer and chief medical officer David Roblin will resign ...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Announces Management Update Oxford, UK, and Cambridge, MA, US, 24...
Summit Therapeutics PLC on Thursday said it secured an additional USD8.8 million funding award from Biomedical Advanc ...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Announces BARDA Expands Ridinilazole Award by $8.8 Million to...
M TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관